Vanessa Broadhurst
Independent Director
Executive Vice President, Global Corporate Affairs, Johnson & Johnson
Director since
July 2022
Committees
Corporate Governance; Quality and Innovation
Other Current Public Company Directorships
None
Ms. Broadhurst provides critical public policy and government affairs expertise from her executive leadership role as Executive Vice President, Global Corporate Affairs at Johnson & Johnson, offering valuable insights on communications, brand reputation management, marketing and regulatory matters affecting the health industry. She brings extensive commercial experience from senior leadership roles across multiple pharmaceutical companies, including responsibility for global commercial strategy, M&A activity, pipeline development and new product launches. Her extensive government relations network, proven ability to navigate complex product challenges and political environments and governance acumen from serving on a Fortune 500 executive team contribute a valuable perspective to Board deliberations.
Skills and Qualifications
Academia
Consumer Products
Digital and Technology
Global Businesses
Human Capital Management
Life Sciences
Marketing and Sales
Mergers and Acquisitions
Research and Development
Currently serves as Executive Vice President, Global Corporate Affairs at Johnson & Johnson, leading corporate marketing, government relations, global communications, public health and philanthropy functions, with previous responsibility as Company Group Chairman for Global Commercial Strategy for Pharmaceuticals, bringing deep expertise in public policy, brand reputation management and strategic communications. Additionally, she possesses expertise in corporate communications strategy, human capital management and an extensive network for advisor recommendations and strategic partnerships.
Extensive commercial and operational experience across the pharmaceutical industry, having served as President of Cardiovascular and Metabolism at Johnson & Johnson and General Manager of multiple business units at Amgen, with proven track record in pipeline development, new product launch strategy and leading M&A activity.
Provides valuable strategic counsel on navigating regulatory and political environments, drawing from experience managing complex product challenges, and serves as a trusted advisor to management on Washington D.C. policy matters, tariff exemptions and pharmaceutical industry positioning with both human and animal health applications.
Career Highlights
Johnson & Johnson (NYSE: JNJ) – a global pharmaceutical and healthcare company
- Executive Vice President, Global Corporate Affairs (2021-present)
- Company Group Chairman, Global Commercial Strategy for Pharmaceuticals (2019- 2021)
- President, Cardiovascular and Metabolism (2017-2018)
- Various senior leadership roles (2017)
Amgen Inc. (NASDAQ: AMGN) – a global biotechnology company
- General Manager, Cardiovascular and Bone Business Units (2014-2017)
- General Manager, Inflammation and Cardiovascular Business Units (2013-2014)
Novartis AG (NYSE: NVS) – a global pharmaceutical company
- Head, Global Gastroenterology Marketing (2003-2005)
Abbott Laboratories (NYSE: ABT) – a global healthcare company
- Various roles of increasing responsibility (1994-2003)
Education
- Bachelor of Arts degree from the University of Colorado
- Master of Business Administration from the Ross School of Business at the University of Michigan (Consortium Fellow)